Geneva Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,311
Closed -$767K 78
2024
Q3
$767K Buy
+1,311
New +$742K 0.33% 48
2023
Q2
Sell
-3,199
Closed -$1.51M 86
2023
Q1
$1.51M Sell
3,199
-1,465
-31% -$707K 1.29% 32
2022
Q4
$2.47M Sell
4,664
-1,769
-27% -$937K 2.34% 18
2022
Q3
$3.25M Sell
6,433
-315
-5% -$166K 3.71% 9
2022
Q2
$3.47M Sell
6,748
-849
-11% -$426K 3.41% 12
2022
Q1
$3.87M Sell
7,597
-335
-4% -$162K 2.39% 18
2021
Q4
$3.98M Buy
7,932
+180
+2% +$81.5K 1.89% 21
2021
Q3
$3.03M Buy
7,752
+4,733
+157% +$1.96M 1.43% 28
2021
Q2
$1.21M Buy
+3,019
New +$1.2M 0.55% 46
2020
Q3
Sell
-3,284
Closed -$969K 96
2020
Q2
$969K Buy
+3,284
New +$941K 0.68% 43
2019
Q1
Sell
-10,870
Closed -$2.71M 72
2018
Q4
$2.71M Sell
10,870
-1,085
-9% -$287K 3.13% 11
2018
Q3
$3.18M Sell
11,955
-766
-6% -$199K 2.44% 11
2018
Q2
$3.12M Buy
12,721
+531
+4% +$128K 2.48% 15
2018
Q1
$2.61M Sell
12,190
-848
-7% -$194K 2.15% 16
2017
Q4
$2.87M Sell
13,038
-240
-2% -$50.9K 2.15% 14
2017
Q3
$2.6M Buy
+13,278
New +$2.57M 2.05% 13
2016
Q2
$3.04M Buy
+16,413
New +$2.19M 2.73% 10

Other funds holding UNH

Geneva Partners's UNH Position: Q4 2024 in Review

Geneva Partners sold out of UnitedHealth (UNH) in Q4 2024, closing a stake of 1,311 shares — an estimated $767K sold.

Geneva Partners first reported a position in UNH in Q2 2016 and held it in 17 quarters. The position peaked at $3.98M in Q4 2021. 3,674 funds tracked by Wall St. Rank hold UNH as of Q4 2024.

  • Geneva Partners reported no remaining UnitedHealth position as of Q4 2024 after selling out during the quarter.
  • Geneva Partners sold 1,311 UnitedHealth shares in Q4 2024, an estimated $767K.
  • Geneva Partners first reported a position in UnitedHealth in Q2 2016 and held it in 17 quarters.
  • Geneva Partners's UnitedHealth position peaked at $3.98M in Q4 2021.
  • 3,674 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2024.

Based on Geneva Partners's 13F filing for Q4 2024, filed 27 Jan 2025.